Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Related Information
Registry Information

Alternate Title

Phase II Randomized Study of Ginger in Patients With Cancer and Chemotherapy-Induced Nausea and Vomiting

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
Phase II	Supportive care	Completed	18 and over	NCCAM, NCI	CCUM-0201 NCT00064272

Special Category: NCI Web site featured trial

Trial Description

Purpose:

The herb ginger may help to reduce or prevent nausea and vomiting in patients receiving chemotherapy for cancer.

This randomized phase II trial is studying how well ginger works in reducing or preventing nausea and vomiting in patients who are receiving chemotherapy for cancer.

Eligibility:

Eligibility criteria include the following:

• At least 18 years old
• Currently receiving a chemotherapy regimen and experiencing nausea and vomiting
• Must have experienced nausea and vomiting while receiving at least one previous chemotherapy regimen
• Scheduled to receive ondansetron, granisetron, or dolasetron while receiving chemotherapy
• No previous chemotherapy regimens doses received on more than 1 day
• More than 1 week since ginger tea, ginger capsules, or ginger tinctures
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will be randomly assigned to one of three groups. Patients in group one will receive low- dose ginger by mouth twice a day. Patients in group two will receive high-dose ginger by mouth twice a day. Patients in group three will receive a placebo by mouth twice a day. Treatment in all groups will begin after chemotherapy and continue for 3 days. Patients will be evaluated at 1 week.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

University of Michigan Cancer Center CCOP Research Base

Suzanna Zick, MPH, ND, Protocol chair		Ph: 734-998-0028; 800-865-1125 Email: szick@umich.edu

Related Information

Featured trial article

Registry Information
Official Title		Phase II Trial Of Encapsulized Ginger As A Treatment For Chemotherapy-Induced Nausea and Vomiting
Trial Start Date		2003-05-27
Trial Completion Date		2007-05-31
Registered in ClinicalTrials.gov		NCT00064272
Date Submitted to PDQ		2003-05-29
Information Last Verified		2007-10-11
NCI Grant/Contract Number		CA46592, CA100612

Back to Top